African Pharmaceutical Leaders Hail Ethiopia’s Manufacturing Growth, Urge Continental Cooperation - ENA English
African Pharmaceutical Leaders Hail Ethiopia’s Manufacturing Growth, Urge Continental Cooperation
Addis Ababa, November 18, 2026 (ENA)—African pharmaceutical stakeholders have expressed strong appreciation for Ethiopia’s progress in pharmaceutical manufacturing and health supply-chain management, describing the country as an important model for other African nations seeking to strengthen local production and improve access to medicines.
The remarks came during the 19th Annual Global Health Supply Chain Summit, which opened in Addis Ababa and runs from November 17 to 19, 2026.
The summit is being held in partnership with the Ethiopian Pharmaceutical Supply Service (EPSS) and the University of Michigan.
Travor Mabugu, a Zimbabwean pharmacist, said Ethiopia’s pharmaceutical industry should be viewed not only as a national achievement but as a potential driver of regional health security.
He argued that Ethiopia’s large population provides a strong domestic market, while its manufacturing capacity could also serve neighboring countries and the wider African region.
“When you look at the pharma industry in Ethiopia, I look at it from the lens of the continent rather than just Ethiopia on its own,” Mabugu said.
“Of course, Ethiopia has got a huge population and it can absorb capacities, but if we are to look at its sustainability and growth, we want to see that capacity being exported to neighboring countries, to the region, and to Africa.”
Mabugu highlighted pooled procurement as a mechanism that could help African-made medicines reach wider markets. “Ethiopia could actually play a big role,” he said.
“We have seen a growing interest in pooled procurement. Unless and until Ethiopia is able to develop its pharmaceutical industry and capabilities, it will only serve its own people. It should be able to export through pooled procurement to other countries and regions so that its products can reach those markets as well.”
Tumelo Mothebe, Director of Supply Chain Management at Lesotho’s Ministry of Health, said Ethiopia’s growth presents both an opportunity and a challenge for other African countries.
He noted that Lesotho has limited pharmaceutical manufacturing capacity, with only one manufacturer producing topical products.
“Ethiopia’s pharmaceutical industry is growing very, very well, and that poses a challenge to all other countries,” Mothebe said. “There is a need for countries to come and benchmark against Ethiopia in order to bring development back to their own countries.”
He added that initiatives such as pooled procurement could open opportunities for smaller countries that might otherwise struggle to compete in pharmaceutical markets.
“The different initiatives that African countries are undertaking, like the pooled procurement system, are bringing diverse opportunities for even smaller countries to explore manufacturing,” he said.
“I believe that for other countries coming into Ethiopia, this will give them good insight into how developments are progressing elsewhere and how they can take advantage of them to improve.”
Bashir Yusuf, from Nigeria’s Ministry of Health, praised Ethiopia’s supply-chain systems after visiting the Ethiopian Pharmaceutical Supply Service. He said the scale, commitment, and competence he observed reflected international standards.
“I think so far, what I’ve seen of Ethiopia is rather fantastic, especially in the areas of supply chain,” Yusuf said.
“I visited the Ethiopian Pharmaceutical Supply Service (EPSS), and what I saw there left me very impressed with the commitment, scale, and competence of the people I met. It is truly of global standards,” he added.